To add insult to injury, many hospitals that aggressively pursue unpaid medical bills profit from a federal drug discount program: the 340B Drug Pricing Program, which was established to help ...

Rescription, Inc., a leading innovator in pharmacy benefit management, is proud to announce it has been awarded a U.S.

Many believe the federal program limits healthcare organizations and hospitals from providing discounted medications.

Amgen is being sued over an alleged unlawful decision to end discounted drug sales to Sagebrush Health Services under the federal 340B Drug Pricing Program. The lawsuit claims the move restricts ...

NuvemRx, a leading tech-enabled pharmacy solutions company for community health providers, today announced it has acquired ...

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

The American Hospital Association is once again raising concerns about how a major drugmaker handles the government’s 340B ...

Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and ...

The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

Medicare’s Maximum Fair Price (MFP) officially went live on January 1st. Select Medicare Part D drugs are now subject to negotiated pricing under the Inflation Reduction Act, with 15 additional Part D ...